AVE 0.00% 0.2¢ avecho biotechnology limited

Shareholder Email 19 December 2023, page-13

  1. 4,547 Posts.
    lightbulb Created with Sketch. 8708
    pray? hope?
    risk / benefit here is the opportunity - the numbers are correct

    https://avecho.com.au/investor-centre/news/2022/12/22/ethics-approval-received-for-phase-iii-clinical-trial/
    https://hotcopper.com.au/data/attachments/5860/5860577-94003d6e0ee83672b31bf5f9c6e02f57.jpg

    others are recognising the value proposition - we know those who have fallen short and others are late to the party and without the right drug candidate
    https://hotcopper.com.au/data/attachments/5860/5860602-ce70f6a4c6ed0344f5c13e76bc5d192f.jpg
    https://puretechhealth.com/programs/details/lyt-310
    https://www.clinicaltrialsarena.com/news/puretech-study-anxiety-treatment/

    red or black

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $540 270K

Buyers (Bids)

No. Vol. Price($)
17 13918600 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41116983 27
View Market Depth
Last trade - 10.35am 05/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.